Contact: Patricia A.  Spinella
Investor Relations
(201) 847-5453
Email: patricia_spinella@bd.com

Colleen T.  White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

Franklin Lakes, NJ (January 14, 2009) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, February 3, 2009, at 1 p.m. (ET).

The webcast can be accessed from the BD corporate website at http://www.bd.com/investors and will be available for replay through Tuesday, February 10, 2009.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.